Gene. I 18 (1992) 267-27 1 0 1992 Elsevier Science Publishers
GENE
B.V. All rights reserved.
261
0378-l 119/92/$05.00
06588
Transcription of the chicken its 52-kDa protein (RNA transcript;
polycistronic;
overlapping
Mathieu H.M. Noteborn”, Alex J. van der Eb a
anemia virus (CAV) genome and synthesis of
ORFs;
Northern
Onno Kranenburga,
blot; dot-blot
Alt Zantema”,
analysis;
S 1 mapping;
in vitro translation)
Guus Kochb, Gerben F. de Boerb and
Ii Laboratory for Molecular Carcinogenesi.~. Sylvius Laboratory. University of Leiden, Leiden, The Netherlands. Tel. 131-71)276115; and h Central Veterinar)j Institute.
Virology Department.
Received
by H. van Ormondt:
Leb:md.
The Netherlands.
21 January
Tel. (31-3200) 76611
1992; Revised/Accepted:
21 March,‘28
March
1992; Received
at publishers:
7 May 1992
SUMMARY
This paper describes the expression of the chicken anemia virus (CAV) genome, a recently characterized single-stranded circular-DNA virus of a new type [Noteborn et al., J. Virol. 65 (1991) 3131-31391. The major transcript from the CAV genome is an unspliced mRNA of about 2100 nucleotides (nt). Its transcription start point and poly(A)-addition site are located at nt 354 and 2317 of the CAV sequence, respectively. In vitro translation experiments provide evidence that the major CAV open reading frame encodes a 52-kDa protein by using the fifth AUG as a start codon of the unspliced CAV mRNA.
INTRODUCTION
Chicken anemia virus (CAV), formerly called chicken anemia agent, transiently causes severe anemia as a result of the destruction of erythroblastoid cells in bone marrow, and immunodeficiency due to the depletion of cortical thymocytes in young chickens (Jeurissen et al., 1989). CAV was first isolated in 1979 by Yuasa et al. (1979). CAV infections are encountered worldwide, and so far only one serotype has been described (McNulty, 1991). Southern analysis and restriction-enzyme mapping showed only
Correspondence
to: Dr. M.H.M.
Carcinogenesis,
University
The Netherlands.
Noteborn,
of Leiden,
Tel. (31-71)276113;
Laboratory
for Molecular
P.O. Box 9503, 2300 RA Leiden, Fax (31-71)276125.
Abbreviations: aa, amino acid(s); bp, base pair(s); CAV, chicken anemia virus; ds, double strand(ed); kb, kilobase or 1000 bp; MuLV, murine leukemia virus; nt. nucleotide(s); ORF, open reading frame; PA, polyacrylamide; Pollk, Klenow (large) fragment of E. coli DNA polymerase I; ss, single strand(ed);
tsp, transcription
start point(s).
minor differences between various field isolates (Noteborn et al., 1992). CAV is a small virus with a virion diameter of 23-25 nm (Gelderblom et al., 1989; Todd et al., 1990). Its genome is a circular ss DNA of about 2.3 kb. Only the minus-strand DNA is encapsidated (Noteborn et al., 1991). One (major) 50-kDa protein was detected in purified virus (Todd et al., 1990). CAV multiplies via a circular ds replicative intermediate. Recently, this 2.3-kb ds DNA was isolated from CAVinfected lymphoblastoid cell lines and cloned in a bacterial vector. The cloned material apparently represents the complete CAV DNA genome and contains all the elements required for the CAV replication cycle and pathogenicity (Noteborn et al., 1991). The cloned CAV genome was proven to be representative for CAV isolates from the field (Noteborn et al., 1992). The genome comprises three partially or completely overlapping ORFs encoding putative proteins of 51.6, 24.0, and 13.6 kDa. The CAV genome contains one obvious promoter upstream from the ORFs and only one poly(A)-addition signal downstream. All ORFs are located on the same DNA strand (Noteborn
268 et al., 1991).These data suggested that the use of the various ORFs may be regulated by alternative splicing, or that CAV encodes a polycistronic mRNA.
A
B
1
In this paper, we report that we detected only one (major) unspliced polyadenylated RNA transcript in CAV-infected cells and provide experimental evidence that the major CAV ORF encodes a 52-kDa protein by using the fifth AUG as start codon of the CAV mRNA.
hours
2 d
kb
-0 -8
4.0-16 2.0EXPERIMENTAL
AND DISCUSSION
-24
1 .o(a) Transcription of the CAV genome To study the transcription of the CAV genome,
0.5MDCC-
MSBl cells (Yuasa, 1983) were infected with CAV-Cux-1 (von Biilow et al., 1983). Two days after infection, when CAV-specific cytopathologic lesions. were visible, total RNA was precipitated from the cell lysates. One (major) CAV transcript of about 2.1 kb was detected in the poly(A)+ RNA fraction of CAV-infected cells. This CAVspecific RNA was absent in mock-infected MDCC-MSB 1 cells (Fig. 1A). Dot-blot analysis showed that CAV RNA was already weakly detectable 8 h after infection, but its level rose enormously at 32 h after infection (Fig. 1B). To investigate the location of the tsp and polyadenylation sites of CAV RNA, nuclease-S 1 mapping of the CAV RNA was performed. The tsp of the CAV RNA was located at nt 354 of the CAV sequence (Noteborn et al., 1991), as shown in Fig. 2A. This conclusion was confirmed by a primer-extension experiment using a 32P-end-labeled CAV DNA primer and MuLV reverse transcriptase (data not shown). Based on the nt sequence, we expected the tsp of the CAV RNA to be around nt 354. A complete set of promoter/enhancer elements is situated upstream from this tsp, such as the TATA box at nt 324. The polyadenylation site was located at nt 2317, which is 25 nt downstream from the only perfect polyadenylation signal (AAUAAA) in CAV RNA (Fig. 2B). The protected DNA smear with a length of 90 to 100 nt might be due to a G+C-rich region around nt 2245, which is predicted to form a stable hairpin and which complicates the nuclease-Sl assay by giving rise to additional protected fragments. In summary, the transcription from CAV DNA starts at nt 354, and terminates at nt 2317. CAV RNA is polyadenylated and has a length of approx. 2100 nt. This implies that the (major) CAV mRNA remains unspliced. (b) Synthesis of the CAV 52-kDa protein The largest ORF (nt 853-2200) encodes a 51.6-kDa protein of 449 aa. In our laboratory, we detected a single 52-kDa protein in CsCl-gradient-purified virus particles (S. Veldkamp, unpublished data). The N-terminal region of the largest ORF encodes an aa sequence which is highly sim-
-32
-48
Fig. 1. Characterization by the LiCl/urea
of CAV RNA synthesis.
method,
finity chromatography formed
as described
and polyadenylated
on oligo(dT)-cellulose. by Laird-Offringa
bridized with a ‘“P-labeled
et al., 1991). (Panel A) Northern RNA from noninfected
of total Cux-I
RNA,
MDCC-MSBl isolated
analysis.
MDCC-MSB
by af-
was per-
Three pg of poly-
1 cells (lane 1) or CAV-
cells (lane 2) were size-fractionated
9~ agarose gel. (Panel B) Dot-blot from MDCC-MSBl
nylon filter (Gelman
Sciences,
analysis.
cells infected
at 0, 8, 16, 24, 36 and 48 h after infection,
Biotrace-RP
analysis
et al. (1990). The RNA was hy-
adenylated
2.2 M formaldehyde-l
Northern
DNA probe derived from the plasmid pCAV/E
(Noteborn
Cux-1 infected
Total RNA was isolated RNA was isolated
with CAV-
was blotted
USA) according
on a Two pg onto a
to Maniatis
et al. (1982).
ilar to histone proteins. Histone proteins are known for their high Arg content and ability to bind and protect DNA (e.g., SwissProt data base, accession Nos. P14402 and PSOOOl). Thus, the N-terminal region of the 5 1.6-kDa CAV protein might have a DNA-binding function, perhaps within the virus capsid. The largest ORF is preceded by 499 nt harboring four AUG triplets. Two other ORFs lie upstream from the largest ORF. One of these terminates only 4 nt before the start codon of the largest ORF, and the other partially overlaps with it (Noteborn et al., 1991). Nuclease-Sl analysis of the potential splice sites in the upstream region of the largest ORF showed that these are not utilized (data not shown). These data imply that the 52-kDa protein is synthesized from the largest CAV ORF of the unspliced CAV RNA with the fifth AUG of the CAV RNA as the start codon. To establish whether the largest ORF is indeed used to produce the 52-kDa protein from the unspliced CAV RNA, we have carried out in vitro translation experiments on a series of plasmids specifying RNAs of increasing length. In vitro transcription of plasmid PEP- 1.96 should yield RNA with the largest ORF preceded by a 5’-upstream region containing four AUGs. From plasmid pEp-1.52, we ex-
269
A
petted RNA with a 62-bp 5’-noncoding no AUGs (Fig. 3). The RNAs derived
B
12CTAG
12CTAG nt
nt 430-
526-
167-
NCOI I
EcoRl LSP’ DNA probe protected
Fig. 2. Nuclease-Sl infected nuclease-S
or
*-
-*
mapping
of CAV RNA. Total RNA (20 pg) of CAV-
mock-infected
1 mapping.
S 1 and the protected
MDCC-MSBl
cells
were
analysed
by
The RNA/DNA
hybrids were treated with nuclease
DNA fragments
were fractionated
64; PA/8 M urea gel, with an nt sequence lengths of the probe and the expected
protected
DNA fragment
The
are indi-
an nt sequence
CAV using DNA primer CAV-1 (Noteborn
PEP-1.52, upon in vitro translation, both yielded a 52-kDa protein (Fig. 4A). This in vitro CAV protein migrates with the same velocity as a protein that could be synthesized in vitro from hybrid-selected RNA of CAV-infected cells, but not from hybrid-selected RNA of noninfected cells (Fig. 4, B and C). However, less 52-kDa protein is produced by RNA derived from PEP- 1.96 than by RNA from PEP- 1.52. Hybrid-selected CAV RNA also yielded at least two other CAV-specific products. Most likely, these products start at AUGs downstream from the start codon of the 52-kDa protein. This hypothesis was supported by comparing the translation products of RNA synthesized in vitro that either still carries the start codon at pos. 853 (Fig. 3: 1.52kb RNA; maximum protein 52-kDa) with RNA from which AUG-853 has been removed (1.44-kb RNA; maximum protein 44 kDa). Both revealed these faster migrating products (Fig. 4C). It is, however, unlikely that the downstream AUGs in the large ORF of CAV RNA serve as start codons in infected cells, since there only the 52-kDa product has been observed (Todd et al., 1990; our own unpublished data). For the translation of the CAV 52-kDa protein, an internal AUG is used as start codon. The use of an internal AUG codon for initiation of translation has been described for other RNAs. Several mechanisms may result in the choice of an internal start codon. For instance, in cases where the upstream AUGs occur in an unfavorable context for translation (Kozak, 1986) an internal start codon may be used. The four AUGs upstream from the CAV 52-kDa ORF, indeed, have unfavorable surrounding sequences, whereas the first AUG in the 52-kDa ORF is the only one in the CAV genome following the Kozak consensus: an A residue at -3, and a G at + 4. Ribosomes might scan the CAV RNA and then start preferentially at the fifth AUG.
on a denaturing
ladder as a length marker.
cated. Lanes C, T, A and G of each panel contain of cloned
ACCI I
*
* DNA
pA 1
region containing from PEP- 1.96 or
ladder
1111
1
IIll
1
I
I
I
1000
500
I,
I
I
I
II
1500
I
et al., 1991). The
DNA fragment
(nt l-43 1, see scheme) was 5’-end-labeled material was fractionated
sis: RNA from mock-infected (lane 2). The zsp is indicated the DNA fragment
and hybridized
cells (lane 1) and from CAV-infected by an asterisk.
cells
1.52-kb
5’-end of
(Panel B) Localization
of
to total RNA.
RNA from CAV-infected is indicated
Lanes:
1, RNA
cells. The position
from mock-infected
by pA. The 32P-labeled 3’-end of the DNA fragment
with an asterisk.
cells; 2,
of the poly(A)-addition
site
is marked
RNA
1.44-kbRNA
the poly(A)-addition site. The 525-bp NcoI-AccI DNA fragment (nt 2150356, see scheme) was 3’Jabeled with PolIk (Maniatis et al., 1982) and hybridized
bp
by electrophore-
by a bent arrow. The ‘*P-labeled
is indicated
I
TGA
sequence reactions were carried out according to Sanger (Maniatis et al., 1982). (Panel A) Localization of the 5’ terminus. The 431-bp EcoRI-EspI with total RNA. The protected
I
2000
Fig. 3. The position
of the largest ORF
CAV RNA relative to the
and the first five AUGs
( x ) of
tspof CAV RNA. The RNAs expressed from
the 1.96-kb, 1.52-kb and 1.44-kb DNA fragments cloned in the in vitro expression vector pEP40 are indicated by solid lines. The position of the
tspis indicated by a bent arrow and of the poly(A)-addition The longest CAV ORF is indicated by the stippled box.
site by ‘PA’.
270
A
B
kDa
’
the 52-kDa ORF might function as a ‘ribosome landing path’, as has been described for RNA of picornaviruses (Pelletier and Sonenberg, 1988) and a cellular mRNA, encoding the immunoglobulin heavy-chain-binding protein
C
123
*
(Macejak and Sarnow, 1991). Although the presence of such a ‘ribosome landing path’ would favor the use of the 5th AUG as start codon, it is rather unlikely in this case. If ribosomes would bind to an internal entry site, one would have expected that the translation efficiencies of the RNAs derived from the 1.96-kb and 1.52-kb DNAs were roughly equal. However, the 449-nt 5’-noncoding region clearly
-69 52-
impaired the translation efficiency of the larger transcript. Further investigations are needed to prove which of the above processes regulate the synthesis of the CAV protein(s). (c) Conclusions
Fig. 4. Synthesis
of the 52-kDa
1.52-kb (nt 792-2319) (xc
protein.
Fig. 3) were each cloned in plasmid
trol of the T7 promoter mids. PEPdownstream
1.96.kb
(Laird-Offringa
pEP40 to come under the conet al., 1989). The resulting
from the coding sequence and transcribed of Promega
(Madison,
cific CAV RNAs was accomplished pCAV/E
plas-
1 cells, essentially
UK). Proteins
et al.
lysate system
by electrophoresis
14”,, PA-O. 1”” SDS gels. Gels were fixed and prepared (Panel A) In vitro translation
or mock-
by McGrogan
in a rabbit-reticulocyte
were fractionated
of spe-
in
for fluorography.
of RNA derived from PEP-1.96
(lane 1) or
I .52 RNA (lane 2). The proteins were labeled with [ ‘JC]leucine
(Amersham, UK). In the control, no RNA was added to the reticulocytc ly sate (lane 3). (Panel B) In vitro translation of hybrid-selected CAV RNA from mock-infected 2). The proteins (Panel
(lane 1) and CAV-infected
MDCC-MSBl
were labeled with [“S]methionine
C) In vitro translation
RNA
We thank Dirk J. van Roozelaar, Ms. Claudia A.J. Verschueren and Sjoerd Veldkamp for excellent technical assistance, and Rob Hoeben and Christiaan Karreman for helpful discussions and computer analysis. This research was made possible with research grants from the Netherlands Ministry of Economic Affairs, and Aesculaap BV, Boxtel, The Netherlands.
cells (lane
(Amersham,
of PEP-1.52-derived
ACKNOWLEDGEMENTS
linearized
from CAV-infected
as described
accord-
selection
with nitrocellulose-bound
(1979). These RNAs were translated (N90, Amersham,
essentially
WI). Hybrid
DNA and RNA isolated
infcctcd MDCC-MSB
from PEP-
(nt 356-2319).
CAV DNA fragments
I .96, PEP- 1.52 and PEP-1 .44, were linearized at the EcoRI site
ing to the protocol plasmid
The
and 1.44-kb (nt 875-2319)
(1) The transcription from CAV DNA starts at nt 354 and terminates at nt 2317. The CAV RNA has a length of about 2100 nt, is polyadenylated and remains unspliced. (2) In vitro, the full-length CAV RNA specifies the 52kDa protein from its longest ORF. (3) Our data strongly suggest that also in vivo the 52kDa protein is synthesized from the largest CAV ORF of the unspliced CAV RNA with the fifth AUG from the 5’-end as the start codon.
UK).
(lane 2) and
PEP-1.44 RNA (lane 3). In the control. no RNA was added to the rcticulocytc lysate (lane 1). The proteins wcrc lab&d with [‘Hlleucine (Amer-
REFERENCES
sham, UK). The symbols
Gelderblom,
* and > denote proteins
derived from hybrid-
selected or in vitro synthcsired CAV RNA, respectively, migration mobility than the 52.kDa CAV protein.
that have a higher
H.. Kling,
Jeurissen,
S.H.M.,
Pal. J.M.A.
of cortical thymocytes (1989) 115-123.
Alternatively, the inefficient translation of the upstream ORFs might be due to the hairpin structure that is predicted by computer analysis between nt 369 and 520. Such an RNA-hairpin structure may impair the scanning of the CAV RNA by ribosomes, resulting in a suppression of initiation at the first two AUGs, as shown for other RNAs (Macejak and Sarnow, 1991). The 5’ region upstream from
S., Lurz,
Morphological characterization Virol. 109 (1989) 115-120.
Kozak,
M.: Bifunctional
R., Tischcr, ofchicken
I. and von Btilow, V.:
anemia agent (CAA). Arch.
and De Boer, G.F.: Transient
induced messenger
by chicken
anemia
depletion
agent. Thymus
RNAs in eukaryotes.
14
Cell 47 (1986)
48 l-483. Laird-Offringa,
I.A.. Elfferich,
P., Knaken,
H.J., De Ruiter, J. and Van
der Eb, A.J.: Analysis of polyadenylation site usage of the c-myc oncogene. Nucleic Acids Res. 17 (1989) 6499-65 14. Laird-Offringa,
I.A., De Wit, C., Elfferich,
P. and Van der Eb, A.J.:
Poly(A)-tail shortcning is the translation-dependent step in c-myc mRNA degradation. Mol. Cell. Biol. IO (1990)6132-6140.
271 Macejak,
D.G. and Sarnow,
P.: Internal initiation oftranslation
by the 5’ leader of a cellular mRNA. Maniatis,
T., Fritsch,
Laboratory Harbor, McGrogan,
E.F.
Manual.
bridization
Sambrook,
Cold Spring
NY, 1982. M., Spector,
H.J.: Purification
and
Nature
J.: Molecular
Harbor
mediated
Laboratory,
Cloning.
A
Cold Spring
D.J., Goldenberg,
C.J., Halbert,
of specific adenovirus
2 RNAs
D. and Raskas,
by preparative
hy-
and selective thermal elution. Nucleic Acids Res. 6 (1979)
M.S.: Chicken
anemia agent: a review. Avian Pathol. 20 (1991)
M.H.M.,
Kranenburg, Zantema,
O.,
De Boer, Vos,
A., Koch,
Characterization all elements
G.F.,
J.G.,
Roozelaar,
Jeurissen,
S.H.M.,
G., Van Ormondt,
of cloned chicken
for the infectious
D.J.,
Karreman, Hoeben,
C., R.C.,
H. and Van der Eb, A.J.:
anemia virus DNA that contains
replication
cycle. J. Virol. 65 (1991)
M.H.M.,
Verschueren,
C.A.J.,
Van Roozclaar,
kamp, S., Van der Eb, A.J. and De Boer, G.F.: Detection
D.J.,
Veld-
of chicken
and polymerase
chain reaction.
21 (1992) 107-118.
J. and Sonenberg,
karyotic
N.: Internal
initiation
of translation
of cu-
mRNA directed by a sequence derived from poliovirus
RNA.
334 (1988) 320-325.
Todd, D., Creelan, J.L., Mackic, D.P., Rixon, Purification and biochemical characterisation
F. and McNulty, M.S.: ofchicken anemia agent.
J. Gen. Virol. 71 (1990) 819-823. von Billow, V., Fuchs, B., Vielitz, B. and Landgraf, H.: Frilhsterblichkeitssyndrom bei Kilken nach Doppelinfektion mit dem Virus des Krankheit
(MDV) und einen Anamic-Errcger
(CAA). J.
Vet. Med. B 30 (1983) 742-750. Yuasa,
N.: Propagation
and infectivity
titration
of the Gifu-l
strain of
chicken
anemia
agent in a cell line (MDCC-MSBl)
derived
Marek’s
disease
lymphoma.
Q. 23 (1983)
Natl. Inst. Anim. Health
from
13-20. Yuasa,
3131-3139. Noteborn,
virus by DNA hybridization
Marekschen
187-203. Noteborn,
Pelletier, Nature
593-607. McNulty,
anemia
Avian Pathol.
353 (1991) 90-94.
N., Taniguichi,
of an agent inducing
T. and Yoshida,
I.: Isolation
and some properties
anemia in chicks. Avian Dis. 23 (1979) 366-385.